Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0684249 (
lung carcinoma
)
23,830
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The critical 8p22 tumor suppressor
deleted in liver cancer 1
(
DLC1
) is frequently inactivated by aberrant CpG methylation and/or genetic deletion and implicated in tumorigeneses of multiple tumor types. Here, we report the identification and characterization of its new isoform,
DLC1
isoform 4 (DLC1-i4). This novel isoform encodes an 1125-aa (amino acid) protein with distinct N-terminus as compared with other known
DLC1
isoforms. Similar to other isoforms,
DLC1
-i4 is expressed ubiquitously in normal tissues and immortalized normal epithelial cells, suggesting a role as a major
DLC1
transcript. However, differential expression of the four
DLC1
isoforms is found in tumor cell lines: Isoform 1 (longest) and 3 (short thus probably nonfunctional) share a promoter and are silenced in almost all cancer and immortalized cell lines, whereas isoform 2 and 4 utilize different promoters and are frequently downregulated.
DLC1
-i4 is significantly downregulated in multiple carcinoma cell lines, including 2/4 nasopharyngeal, 8/16 (50%) esophageal, 4/16 (25%) gastric, 6/9 (67%) breast, 3/4 colorectal, 4/4 cervical and 2/8(25%)
lung carcinoma
cell lines. The functional
DLC1
-i4 promoter is within a CpG island and is activated by wild-type p53. CpG methylation of the
DLC1
-i4 promoter is associated with its silencing in tumor cells and was detected in 38-100% of multiple primary tumors. Treatment with 5-aza-2'-deoxycytidine or genetic double knockout of DNMT1 and DNMT3B led to demethylation of the promoter and reactivation of its expression, indicating a predominantly epigenetic mechanism of silencing. Ectopic expression of
DLC1
-i4 in silenced tumor cells strongly inhibited their growth and colony formation. Thus, we identified a new isoform of
DLC1
with tumor suppressive function. The differential expression of various
DLC1
isoforms suggests interplay in modulating the complex activities of
DLC1
during carcinogenesis.
...
PMID:A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors. 2121 78